Cargando…
The role of hormonal factors and endocrine therapy in ovarian cancer
The efficacy of the second-line chemotherapy commonly used in both relapsed ovarian cancer patients and those with primary treatment failure remains unsatisfactory. This therapy has a small effect on survival, whereas associated toxicity may diminish the patient's quality of life. Hormonal fact...
Autores principales: | Serkies, Krystyna, Sinacki, Marcin, Jassem, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685340/ https://www.ncbi.nlm.nih.gov/pubmed/23788955 http://dx.doi.org/10.5114/wo.2013.33768 |
Ejemplares similares
-
Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
por: Serkies, Krystyna, et al.
Publicado: (2011) -
Radiation dose to the left anterior descending coronary artery during interstitial pulsed-dose-rate brachytherapy used as a boost in breast cancer patients undergoing organ-sparing treatment
por: Sinacki, Marcin, et al.
Publicado: (2017) -
Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2016) -
Castleman’s disease mimicking lymph node metastases in a young woman with laryngeal cancer
por: Serkies, Krystyna, et al.
Publicado: (2016) -
Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2009)